Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact

Impact · against what's priced in

Boston Scientific's price is under pressure as the 2027 trough guidance extends the recovery horizon beyond what the market had already discounted. Medtronic and Abbott remain largely unaffected as the disruption is specific to BSX's operations rather than a systemic sector shift.

BSX−0.60

Challenges what's priced in

The price assumes